Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $738.8700 (-0.06%) ($738.8700 - $745.5650) on Fri. Nov. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.91% (three month average) | RSI | 45 | Latest Price | $738.8700(-0.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) DIA(31%) SPLV(28%) IWD(26%) SDY(25%) | Factors Impacting REGN price | REGN will decline at least -1.455% in a week (0% probabilities). TBT(-14%) URA(-4%) EDOC(-4%) VCSH(-3%) ARKG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.455% (StdDev 2.91%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $741.52 | 5 Day Moving Average | $737.36(0.2%) | 10 Day Moving Average | $740.51(-0.22%) | 20 Day Moving Average | $741.52(-0.36%) | To recent high | -2.8% | To recent low | 28.8% | Market Cap | $78.341b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |